Infliximab for reversible dementia in acute onset of neuro-Behçet's disease: A case report and cytokine analysis
Authors:
- Keisuke ImabayashiKIKeisuke Imabayashi
- Masahiro AyanoMAMasahiro Ayano
- Kazuhiko HigashiokaKHKazuhiko Higashioka
- Ken YamamotoKYKen Yamamoto
- Koji TakayamaKTKoji Takayama
- Hiroki MitomaHMHiroki Mitoma
- Yasutaka KimotoYKYasutaka Kimoto
- Yojiro ArinobuYAYojiro Arinobu
- Koichi AkashiKAKoichi Akashi
- Takahiko HoriuchiTHTakahiko Horiuchi
- 1 August 2021
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 357, 577631
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteriaJournal of the European Academy of Dermatology and Venereology, 2013
- Transmembrane TNF- : structure, function and interaction with anti-TNF agentsRheumatology, 2010
- A case study of Neuro-psycho-Behçet's Syndrome presenting with psychotic attackClinical Neurology and Neurosurgery, 2009
- Effect of infliximab in progressive Neuro-Behçet's syndromeJournal of the Neurological Sciences, 2008
- Mechanisms for cytotoxic effects of anti–tumor necrosis factor agents on transmembrane tumor necrosis factor α–expressing cells: Comparison among infliximab, etanercept, and adalimumabArthritis & Rheumatism, 2008
- CXCL10‐induced cell death in neurons: role of calcium dysregulationEuropean Journal of Neuroscience, 2006
- Cytokines and chemokines in neuro-Behçet's disease compared to multiple sclerosis and other neurological diseasesJournal of Neuroimmunology, 2003
- Basal ganglia and cerebellar loops: motor and cognitive circuitsBrain Research Reviews, 2000
- Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patientsBrain, 1999
- Cerebrospinal Fluid Interleukin-6 in Progressive Neuro-Behçet's SyndromeClinical Immunology and Immunopathology, 1997